Endurance Wealth Management’s Cabaletta Bio CABA Stock Holding History

Endurance Wealth Management’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$11K	Hold	800	–	–	﹤0.01%	484
2023 Q1	$0	Hold	800	–	–	﹤0.01%	642
2022 Q4	$7K	Hold	800	–	–	﹤0.01%	501
2022 Q3	$1K	Hold	800	–	–	﹤0.01%	585
2022 Q2	$1K	Hold	800	–	–	﹤0.01%	598
2022 Q1	$2K	Hold	800	–	–	﹤0.01%	599
2021 Q4	$3K	Hold	800	–	–	﹤0.01%	563
2021 Q3	$10K	Hold	800	–	–	﹤0.01%	522
2021 Q2	$6K	Hold	800	–	–	﹤0.01%	553
2021 Q1	$9K	Buy	+800	New	+$9.77K	﹤0.01%	533

Other funds holding CABA

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Endurance Wealth Management's CABA Position: Q2 2023 in Review

Endurance Wealth Management held its Cabaletta Bio (CABA) position steady in Q2 2023 at 800 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #484.

Endurance Wealth Management first reported a position in CABA in Q1 2021 and has held it in 10 quarters since. 84 funds tracked by Wall St. Rank hold CABA as of Q2 2023.

Endurance Wealth Management held 800 shares of Cabaletta Bio worth $11K as of Q2 2023.
Endurance Wealth Management left its Cabaletta Bio share count unchanged in Q2 2023.
Cabaletta Bio made up ﹤0.01% of Endurance Wealth Management's portfolio in Q2 2023, its #484 holding.
Endurance Wealth Management first reported a position in Cabaletta Bio in Q1 2021 and has held it in 10 quarters since.
84 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2023.

Based on Endurance Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.